Icon Plc Revenue Growth Rates (ICLR), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Icon Plc  (NASDAQ: ICLR)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

ICLR's Revenue Growth by Quarter and Year

Icon Plc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ICLR Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 2,063.49
1st Quarter March 2,034.00
FY 4,097.49

ICLRs Annual Revenue
Icon Plc's Revenue in the fiscal year 2025 $ 8,251.34 millions
Icon Plc's Revenue in the fiscal year 2024 $ 8,281.68 millions
Icon Plc's Revenue in the fiscal year 2023 $ 8,120.18 millions
Icon Plc's Revenue in the fiscal year 2022 $ 7,741.39 millions
Icon Plc's Revenue in the fiscal year 2021 $ 5,480.83 millions




ICLR Revenue second quarter 2026 Y/Y Growth Comment
Icon Plc reported Revenue growth of 1.2% year on year in the second quarter 2026, to $ 2,063.49 millions, this is lower than Icon Plc's recent average Revenue increase of 18.03%.

Looking into second quarter 2026 results within Medical Laboratories industry 2 other companies have achieved higher Revenue growth. While Icon Plc' s Revenue increase of 1.2% ranks overall at the positon no. 244 in the second quarter 2026.


ICLR Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 7.29 % -74.86 % 313.87 %
3rd Quarter September - 2.08 % - -
2nd Quarter June 1.2 % - - -
1st Quarter March 0.93 % - - -
FY   - 103.98 % -49.72 % -

Financial Statements
Icon Plc's second quarter 2026 Revenue $ 2,063.49 millions ICLR's Income Statement
Icon Plc's second quarter 2025 Revenue $ 2,039.09 millions Quarterly ICLR's Income Statement


ICLR Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 5.06 % -0.04 % -
3rd Quarter September - 2.22 % - -
2nd Quarter June 1.45 % 1.18 % - -
1st Quarter March -7.12 % -1.26 % - -
FY (Year on Year)   - 103.98 % -49.72 % -


Back to ICLR Growth rate Comparisons >> Back to ICLR Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #3
Healthcare Sector #61
Overall #244

Revenue Y/Y Growth Statistics
High Average Low
95.93 % 18.03 % -0.37 %
(Dec 31 2021)  
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #3
Healthcare Sector #61
Overall #244
Revenue Y/Y Growth Statistics
High Average Low
95.93 % 18.03 % -0.37 %
(Dec 31 2021)  

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Icon Plc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
292.79 % 8.2 % -100 %
(Dec 31 2011)  


ICLR's II. Quarter Q/Q Revenue Comment
Icon Plc achieved in the II. Quarter 2026 below company average Revenue growth of 1.45% quarter on quarter, to $ 2,063.49 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 1.18% in the II. Quarter a year ago.

Within Medical Laboratories industry 25 other companies have achieved higher Revenue quarter on quarter growth. While Icon Plc's Revenue growth quarter on quarter, overall rank is 2140.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #26
Healthcare Sector #397
Overall #2140
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #26
Healthcare Sector #397
Overall #2140
Revenue Q/Q Growth Statistics
High Average Low
292.79 % 8.2 % -100 %
(Dec 31 2011)  


ICLR's II. Quarter Q/Q Revenue Comment
Icon Plc achieved in the II. Quarter 2026 below company average Revenue growth of 1.45% quarter on quarter, to $ 2,063.49 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 1.18% in the II. Quarter a year ago.

Within Medical Laboratories industry 25 other companies have achieved higher Revenue quarter on quarter growth. While Icon Plc's Revenue growth quarter on quarter, overall rank is 2140.


Icon Plc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Dec 31 2021)
Cumulative Revenue 12 Months Ending $ 8,251.34 $ 8,281.68 $ 8,120.18 $ 7,741.39 $ 5,480.83
Y / Y Revenue Growth (TTM) -0.37 % 1.99 % 4.89 % 41.24 % 95.93 %
Year on Year Revenue Growth Overall Ranking # 244 # 126 # 128 # 0 # 0
Seqeuential Revenue Change (TTM) -0.37 % 1.99 % 4.89 % 41.24 % 95.93 %
Seq. Revenue Growth (TTM) Overall Ranking # 244 # 2529 # 129 # 0 # 0


Cumulative Revenue growth Comment
For the 12 months ended Dec 31 2025 Icon Plc reported a decrease in Revenue by -0.37% year on year, to $8,251 millions, compare to the 1.99% growth at Dec 31 2024.

In the Healthcare sector 60 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 126 to 244.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 3
Healthcare Sector # 61
Overall # 244

Revenue TTM Y/Y Growth Statistics
High Average Low
95.93 %
 18.03 %
-0.37 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 61
S&P 500 # 244
Cumulative Revenue growth Comment
For the 12 months ended Dec 31 2025 Icon Plc reported a decrease in Revenue by -0.37% year on year, to $8,251 millions, compare to the 1.99% growth at Dec 31 2024.

In the Healthcare sector 60 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 126 to 244.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 3
Healthcare Sector # 61
Overall # 244

Revenue TTM Y/Y Growth Statistics
High Average Low
95.93 %
18.03 %
-0.37 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 61
S&P 500 # 244




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ICLR's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Co diagnostics Inc 1.98%$ 1.977 millions
Rxsight Inc 1.66%$ 1.660 millions
Bioage Labs Inc 1.62%$ 1.617 millions
Icon Plc1.20%$ 1.197 millions
Bio techne Corp1.06%$ 1.063 millions
Tela Bio Inc 0.97%$ 0.974 millions
Integra Lifesciences Holdings Corp0.76%$ 0.759 millions
Icu Medical Inc0.66%$ 0.660 millions


About Icon Plc Revenue Growth Rates (ICLR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Icon Plc (CIK 1060955).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-038487
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Icon Plc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.